Scarica l'app Stockscreener
205.44
1.47%
-3.395
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché ABBV Giù?
Forum
Previsione
Storia dei dividendi
Abbvie Inc Borsa (ABBV) Ultime notizie
Scotiabank Maintains AbbVie(ABBV.US) With Buy Rating, Maintains Target Price $280 - Moomoo
How Will Skyrizi and Rinvoq Shape AbbVie's Q1 Immunology Sales? - TradingView
AbbVie Lowers 2026 Earnings Guidance Amid Expenses - Intellectia AI
Sowell Financial Services LLC Has $10.85 Million Position in AbbVie Inc. $ABBV - MarketBeat
AbbVie forecasts $744M hit from drug pipeline costs - Crain's Chicago Business
The Best Dividend ETF to Buy in April 2026 If You Want Passive Income - The Motley Fool
AbbVie Inc. $ABBV Shares Purchased by Kelleher Financial Advisors - MarketBeat
AbbVie Inc. $ABBV Shares Purchased by JB Capital LLC - MarketBeat
Savvy Advisors Inc. Buys 6,646 Shares of AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. (ABBV) stock price, news, quote and history - Yahoo Finance Singapore
AbbVie Inc. $ABBV is Advocate Group LLC's 4th Largest Position - MarketBeat
AbbVie's Financial Outlook Revised Amid Pipeline Progress and One-Time Charge - AD HOC NEWS
AbbVie Updates 2026 Adjusted EPS Guidance to $13.96–$14.16 Including Q1 Acquired IPR&D and Milestones Expense 1 - Minichart
AbbVie Inc. $ABBV Shares Bought by SteelPeak Wealth LLC - MarketBeat
Thurston Springer Miller Herd & Titak Inc. Acquires 6,946 Shares of AbbVie Inc. $ABBV - MarketBeat
C2P Capital Advisory Group Trims AbbVie Stake - National Today
C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors Sells 8,610 Shares of AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. (ABBV) latest stock news and headlines - Yahoo Finance Australia
AbbVie reports $744 million IPR&D expense for Q1, updates 2026 earnings guidance - Investing.com
AbbVie & Amgen: Safe Dividend Stocks for Recession Fears | 2026News and Statistics - indexbox.io
Open Angle Glaucoma Market: Expanding Revenue Landscape to 2034 – DelveInsight | Visiox Pharma, TearClear, VivaVision Biotech, Abbvie, Ocuphire Pharma, Qlaris Bio, Nicox Ophthalmics, Sun Pharma - barchart.com
AbbVie Posts Record $61B Revenue as Skyrizi and Rinvoq Surge Past Peak Humira Sales - TIKR.com
Potential US Drug Tariffs Test AbbVie Margins And Growth Narrative - Yahoo Finance
AMN Healthcare Services, DaVita, Bristol-Myers Squibb, Novavax, and AbbVie Shares Plummet, What You Need To Know - Yahoo Finance
Global pharma companies that have publicly announced Trump drug pricing agreements - Reuters
AbbVie Inc Stock (ABBV) Moved Down by 3.20% on Apr 2: A Full Analysis - tradingkey.com
AbbVie stock price forecast: Downside risk builds as ABBV drops 3.07% to $208 - Traders Union
AbbVie Inc. $ABBV Shares Sold by Trust Co. of Vermont - MarketBeat
Assessing AbbVie (ABBV) Valuation After New Dermatology Data And FDA Label Update - Yahoo Finance
Compagnie Lombard Odier SCmA Raises Holdings in AbbVie Inc. $ABBV - MarketBeat
Banque Pictet & Cie SA Has $88.87 Million Stock Position in AbbVie Inc. $ABBV - MarketBeat
What You Need to Know Ahead of AbbVie’s Earnings Release - Barchart
AbbVie Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Thrivent Moderate Allocation Fund's AbbVie Inc(ABBV) Holding History - gurufocus.com
AbbVie Inc. $ABBV Stock Holdings Trimmed by Vaughan Nelson Investment Management L.P. - MarketBeat
Nisa Investment Advisors LLC Has $156 Million Stock Position in AbbVie Inc. $ABBV - MarketBeat
Moody Lynn & Lieberson LLC Has $43.98 Million Holdings in AbbVie Inc. $ABBV - MarketBeat
Meyer Handelman Co. Boosts Stock Holdings in AbbVie Inc. $ABBV - MarketBeat
Sarcopenia Treatments Market Is Going to Boom | AbbVie • Amgen • Pfizer • Novartis - openPR.com
AbbVie Inc. $ABBV Shares Bought by Capital Advisors Inc. OK - MarketBeat
AbbVie Inc. $ABBV Shares Sold by Allspring Global Investments Holdings LLC - MarketBeat
AbbVie (NYSE:ABBV) Shares Up 2%Time to Buy? - MarketBeat
AbbVie Inc. stock rises Tuesday, still underperforms market - MarketWatch
Pfizer, Bain Must Litigate Cerevel Investors’ AbbVie Deal Suit - Bloomberg Law News
ABBV Stock Quote Price and Forecast - CNN
Bernstein Maintains AbbVie(ABBV.US) With Hold Rating, Maintains Target Price $225 - 富途牛牛
AbbVie Inc Stock (ABBV) Moved Up by 3.26% on Mar 31: Drivers Behind the Movement - TradingKey
/C O R R E C T I O N -- AbbVie/ - Investing News Network
Will AbbVie's Oncology Drugs Aid Top Line in 2026? - The Globe and Mail
Allergan Aesthetics Announces Fourth Annual, All-Access CoolMonth with Deals on CoolSculpting - Investing News Network
Allergan Aesthetics Announces Fourth Annual, All-Access CoolMonth with Deals on CoolSculpting® - AbbVie News Center
AbbVie to Host First-Quarter 2026 Earnings Call - National Today
AbbVie to Host First-Quarter 2026 Earnings Conference Call - Moomoo
Range Financial Group LLC Has $1.08 Million Holdings in AbbVie Inc. $ABBV - MarketBeat
J. Safra Sarasin Holding AG Reduces AbbVie Stake - National Today
J. Safra Sarasin Holding AG Sells 36,172 Shares of AbbVie Inc. $ABBV - MarketBeat
AbbVie Inc. $ABBV Holdings Lifted by Mn Services Vermogensbeheer B.V. - MarketBeat
Financial Planning Hawaii Inc. Invests $2.90 Million in AbbVie Inc. $ABBV - MarketBeat
AbbVie Stock Price Rises 1.8%, Analysts Weigh In - National Today
AbbVie (NYSE:ABBV) Stock Price Up 1.8%Should You Buy? - MarketBeat
AbbVie (ABBV) Gains As Market Dips: What You Should Know - Yahoo Finance
AbbVie Inc. stock outperforms competitors on strong trading day - MarketWatch
0.08%
0.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):